EP1272624A4 - A process for the production of human interferon alpha from genetically engineered yeast - Google Patents

A process for the production of human interferon alpha from genetically engineered yeast

Info

Publication number
EP1272624A4
EP1272624A4 EP00909584A EP00909584A EP1272624A4 EP 1272624 A4 EP1272624 A4 EP 1272624A4 EP 00909584 A EP00909584 A EP 00909584A EP 00909584 A EP00909584 A EP 00909584A EP 1272624 A4 EP1272624 A4 EP 1272624A4
Authority
EP
European Patent Office
Prior art keywords
production
genetically engineered
interferon alpha
human interferon
engineered yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00909584A
Other languages
German (de)
French (fr)
Other versions
EP1272624A1 (en
Inventor
Kondra Venkat Sudhir
Chaganti Revathi Jogulamma
Akundi Venkata Sriram
Kolli Satya Narayana Prasad
Kondiboyina Venkata Ramana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shantha Biotechnics Pvt Ltd
Original Assignee
Shantha Biotechnics Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shantha Biotechnics Pvt Ltd filed Critical Shantha Biotechnics Pvt Ltd
Publication of EP1272624A1 publication Critical patent/EP1272624A1/en
Publication of EP1272624A4 publication Critical patent/EP1272624A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
EP00909584A 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast Withdrawn EP1272624A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/000339 WO2001068827A1 (en) 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast

Publications (2)

Publication Number Publication Date
EP1272624A1 EP1272624A1 (en) 2003-01-08
EP1272624A4 true EP1272624A4 (en) 2004-06-16

Family

ID=11003897

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00909584A Withdrawn EP1272624A4 (en) 2000-03-16 2000-03-16 A process for the production of human interferon alpha from genetically engineered yeast

Country Status (6)

Country Link
EP (1) EP1272624A4 (en)
JP (1) JP2003526365A (en)
CN (1) CN1452658A (en)
AU (1) AU2000231863A1 (en)
CA (1) CA2402562A1 (en)
WO (1) WO2001068827A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060223145A1 (en) * 2002-11-01 2006-10-05 Lohray Braj B Method for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris
AU2008201682B2 (en) * 2004-02-02 2011-02-24 Ambrx, Inc. Modified human interferon polypeptides and their uses
NZ586034A (en) 2004-02-02 2011-10-28 Ambrx Inc Modified human growth hormone polypeptides and their uses
CU24158B1 (en) * 2012-09-18 2016-03-30 Ct De Ingeniería Genética Y Biotecnología 1-KESTOSA OBTAINING METHOD

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0606917A2 (en) * 1993-01-13 1994-07-20 The Green Cross Corporation A methylotropic and glucotropic mutant strain for producing a heterologous protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90021A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Process for the production of interferon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0606917A2 (en) * 1993-01-13 1994-07-20 The Green Cross Corporation A methylotropic and glucotropic mutant strain for producing a heterologous protein

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CREGG J M ET AL: "RECENT ADVANCES IN THE EXPRESSION OF FOREIGN GENES IN PICHIA PASTORIS", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, vol. 11, no. 8, August 1993 (1993-08-01), pages 905 - 910, XP001093882, ISSN: 0733-222X *
ROSENFELD: "Use of P. pastoris for expression of recombinant proteins", METHODS IN ENZYMOLOGY, vol. 306, 1999, pages 154 - 169, XP009029632 *
See also references of WO0168827A1 *

Also Published As

Publication number Publication date
JP2003526365A (en) 2003-09-09
CA2402562A1 (en) 2001-09-20
AU2000231863A1 (en) 2001-09-24
WO2001068827A1 (en) 2001-09-20
EP1272624A1 (en) 2003-01-08
CN1452658A (en) 2003-10-29

Similar Documents

Publication Publication Date Title
AU2001227573A1 (en) Ceramics and process for producing
HUP0402027A3 (en) Process for the preparation of a xantophyll
EP1466596A4 (en) Novel microsphere and method for production thereof
EP1405912A4 (en) Genetically modified ecarin and process for producing the same
HU9901526D0 (en) Pharmaceutical intermediates and process for producing them
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
EP1406855A4 (en) Novel process for preparing rac-bicalutamide and its intermediates
EP1391518A4 (en) Process for producing peptide
PL363181A1 (en) Modified interferon alpha with reduced immunogenicity
EP1272624A4 (en) A process for the production of human interferon alpha from genetically engineered yeast
EP1484056A4 (en) Sustained release preparations and process for producing the same
AU2003291476A8 (en) Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
SG92800A1 (en) Process for the production of vinyl acetate
AU2003247023A8 (en) A process for the preparation of dispersible tablet of cephalexin
IL152996A0 (en) Novel interferon for the treatment of multiple sclerosis
GB2397819B (en) (R)-Hydroxycarboxylic acid producing recombinant microorganism and process for preparing (R)-hydroxycarboxylic acid using the same
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
IL144809A0 (en) Method for the production of aliphatic fluoroformates
MXPA03002221A (en) Coupled production of two esters.
AU3185400A (en) A process for producing purified biologically active, free form of recombinant human interferon gamma
HUP0301635A3 (en) Continuous process for the production of optically pure (s)-betha-hydroxy-gamma-butyrolactone
AU7964000A (en) Process for producing ball-shape food
HUP0104761A3 (en) Modification of interferon alpha production
IL147529A0 (en) A method for the production of soybean sugars and the product produced thereof
PL372298A1 (en) Method for producing interferon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021010

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040503

17Q First examination report despatched

Effective date: 20050401

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SHANTHA BIOTECHNICS LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081001